STAT@ASCO: Fueling the Fight Against Cancer

   Convene - W Adams St. at 16 W Adams St, Chicago, IL 60603

  June 3, 5:30 - 9:00 p.m. CT

As doctors and researchers return to ASCO, STAT reporters will sit down with newsmakers driving science and cancer policy and dig in to what we expect to learn over a packed four days at the biggest gathering for cancer research and the biotech industry. 

 

AGENDA

5:30 PM CT - Registration + Networking

Drinks will be served. Masks strongly encouraged except when actively eating or drinking.

6:15 PM CT - Welcome from STAT

Matthew Herper, senior writer, medicine; editorial director of events, STAT

6:20 PM CT - Welcome Remarks | SPONSOR SESSION

Levi Garraway, M.D., Ph.D., chief medical officer, executive vice president and head of global product development, Genentech

6:25 PM CT - Cancer’s Gatekeeper Speaks

Richard Pazdur runs the FDA's Oncology Center of Excellence -- and that means his opinions on how well cancer drugs must perform in order to be approved matters a great deal in the U.S. Come hear his latest thinking on targeted medicines, immunotherapy, and the latest innovations in medicine.

Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence; acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research

Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

6:55 PM CT - Fireside Chat | SPONSOR SESSION

Levi Garraway, M.D., Ph.D., chief medical officer, executive vice president and head of global product development, Genentech

Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

7:05 PM CT - Sitdown With a Breakthrough Scientist

Elizabeth Budde, M.D., Ph.D., Associate professor, division of lymphoma, department of hematology & hematopoietic cell transplantation, City of Hope

Jennifer Litton, M.D., Vice president of clinical research and professor of breast medical oncology at The University of Texas MD Anderson Cancer Center

Professor Mary O’Brien, Consultant medical oncologist and head of the Lung Unit, The Royal Marsden NHS Foundation Trust; professor of practice (medical oncology), Imperial College London

Elizer Van Allen, M.D., Chief of Population Sciences at Dana-Farber Cancer Institute; associate Professor of Medicine at Harvard Medical School; associate Member of the Broad Institute of MIT and Harvard

Angus Chen, Cancer reporter, STAT(moderator)

7:40 PM CT - Closing Remarks

7:45 PM CT - Networking Reception

Drinks and light bites will be served. Masks strongly encouraged except when actively eating or drinking.